Purpose: To evaluate the long-term corneal safety of topical mitomycin C (MMC) used during
photorefractive keratectomy to prevent haze formation in highly myopic eyes. Methods …

PURPOSE: To evaluate the role of topical mitomycin C in corneal wound healing (CWH)
after photorefractive keratectomy (PRK) in highly myopic eyes. DESIGN: Prospective, double …

PURPOSE: To evaluate the safety and efficacy of 5 seconds of mitomycin-C (MMC)
application during photorefractive keratectomy (PRK) for low myopia. SETTING: Basir Eye …

Background To study the effect of prophylactic application of mitomycin-C on haze formation
in photorefractive keratectomy (PRK) for high myopia. Methods Fifty-four eyes of 28 myopic …

Photorefractive keratectomy (PRK) is considered a safe approach laser procedure with a
clinical significance in correcting myopia results. PRK requires removing the whole …

Purpose This study investigated the effect of prophylactic mitomycin C (MMC) on corneal
endothelium to inhibit corneal haze formation post transepithelial photorefractive …

Purpose To evaluate the safety and efficacy of mitomycin-C (MMC) 0.01%(0.1 mg/mL) in
preventing haze formation after wavefront-guided photorefractive keratectomy (PRK) for …

ABSTRACT PURPOSE: To evaluate the efficacy, safety, and predictability of therapeutic
scraping and application of a diluted 0.02% mitomycin C solution to treat haze and …

Purpose: To evaluate the effect of topical mitomycin C (MMC) after myopic photorefractive
keratectomy (PRK) on epithelialization and predictability. Methods: Prospective …

OBJECTIVE: To determine whether the duration of mitomycin C (MMC) 0.02% application
affects visual outcome or the incidence of subepithelial haze in patients undergoing …